NCIC Clinical Trials Group: all 116 studies

Page 1 of 2. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal CarcinomaCompletedNCT01830621Phase 3Results posted
• A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate CancerCompletedNCT01331083Phase 2Results posted
• A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or ProgressionCompletedNCT01259869Phase 2Results posted
• Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone MetastasesCompletedNCT01248585Phase 3Results posted
• Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent MelanomaCompletedNCT01152788Phase 2Results posted
• PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic CancerCompletedNCT01000025Phase 3Results posted
• Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck CancerCompletedNCT00820248Phase 3Results posted
• Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00795340Phase 3Results posted
• Observation or Radical Treatment in Patients With Prostate CancerTerminatedNCT00499174Not applicableResults posted
• Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast CancerCompletedNCT00083174Phase 3Results posted
• Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone MetastasesCompletedNCT00080912Not applicableResults posted
• Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00078949Phase 3Results posted
• Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast CancerCompletedNCT00066573Phase 3Results posted
• Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple MyelomaCompletedNCT00049673Phase 3Results posted
• Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerCompletedNCT00014222Phase 3Results posted
• Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast CancerCompletedNCT00005957Not applicableResults posted
• Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With NeuroblastomaWithdrawnNCT01916187Phase 1
• A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell LymphomaCompletedNCT01652144Phase 2
• A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01627054Phase 2
• A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT01486368Phase 2
• A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and LeukemiaCompletedNCT01184274Phase 1
• A Study of Foretinib in Patients With Recurrent/Metastatic Breast CancerCompletedNCT01147484Phase 2
• A Study of AT9283 in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01145989Phase 2
• Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast CancerCompletedNCT01138384Phase 1/2
• A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic SarcomasCompletedNCT01112384Phase 2
• SB939 in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT01075308Phase 2
• MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous ChemotherapyCompletedNCT01068587Phase 1/2
• Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer PainTerminatedNCT00930332Phase 1
• MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00869752Phase 1/2
• Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial CancerCompletedNCT00770185Phase 2
• Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3CompletedNCT00688246
• Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary CancerTerminatedNCT00658593Phase 3
• Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate CancerTerminatedNCT00651326Phase 3
• Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal CancerCompletedNCT00640471Phase 3
• AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNCT00535353Phase 1
• Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00516828Phase 1/2
• Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant MelanomaCompletedNCT00514085Phase 2
• SB939 in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00504296Phase 1
• Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00482755Phase 2
• OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
• Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00443976Phase 1
• Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaCompletedNCT00428142Phase 2
• AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaCompletedNCT00390117Phase 1
• Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma MultiformeCompletedNCT00387400Phase 1
• Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell LymphomaCompletedNCT00377052Phase 2
• AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid TumorsCompletedNCT00372736Phase 1
• AEG35156 and Docetaxel in Treating Patients With Solid TumorsCompletedNCT00357747Phase 1
• Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical TrialCompletedNCT00354302Phase 3
• BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerTerminatedNCT00352079Phase 3
• Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00346320Not applicable
• AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerCompletedNCT00343408Phase 1
• Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple MyelomaCompletedNCT00305812Phase 2
• AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00265876Phase 1/2
• Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone TherapyCompletedNCT00258388Phase 2
• OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00258375Phase 2
• Everolimus in Treating Patients WIth Recurrent or Metastatic Breast CancerCompletedNCT00255788Phase 2
• Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00245154Phase 2/3
• Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast DensityCompletedNCT00238316Phase 2
• AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)CompletedNCT00107250Phase 1
• SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver CancerCompletedNCT00095992Phase 2
• SB-715992 in Treating Patients With Metastatic or Recurrent Malignant MelanomaCompletedNCT00095953Phase 2
• Sorafenib in Treating Patients With Metastatic or Recurrent Prostate CancerCompletedNCT00093457Phase 2
• Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland TumorCompletedNCT00079079Phase 2
• Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal CancerCompletedNCT00079066Phase 3
• Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00079053Phase 1
• 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell CarcinomaCompletedNCT00075660Phase 2
• Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerCompletedNCT00066586Not applicable
• Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast CancerCompletedNCT00066443Phase 1/2
• Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate NeoplasiaCompletedNCT00064194Phase 3
• Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's LymphomaCompletedNCT00064116Phase 3
• Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate CancerCompletedNCT00054106Phase 1
• Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaCompletedNCT00053794Phase 2
• Perifosine in Treating Patients With Metastatic or Recurrent Malignant MelanomaCompletedNCT00053781Phase 2
• Fludarabine in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00049075Phase 2
• Bortezomib in Treating Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00045695Phase 2
• SarCNU in Treating Patients With Recurrent Malignant GliomaCompletedNCT00036660Phase 2
• Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell TransplantationCompletedNCT00031668Not applicable
• Bortezomib in Treating Patients With Mantle Cell LymphomaCompletedNCT00030875Phase 2
• Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00030446Phase 2
• Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00028743Phase 3
• SarCNU in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00028015Phase 2
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic CancerCompletedNCT00026338Phase 3
• ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00025116Phase 2
• Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenCompletedNCT00016380Phase 3
• Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous TreatmentCompletedNCT00014209Phase 2
• Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial CancerCompletedNCT00010179Phase 2
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00006890Phase 2
• Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00006229Phase 2/3
• Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00006036Phase 1
• Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00005974Phase 2
• Flavopiridol in Treating Patients With Metastatic Malignant MelanomaCompletedNCT00005971Phase 2
• Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell LymphomaCompletedNCT00005074Phase 2
• Letrozole in Treating Women With Recurrent or Metastatic Endometrial CancerCompletedNCT00004251Phase 2
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or LarynxCompletedNCT00004234Phase 3
• ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian CancerCompletedNCT00003892Phase 2
• Lurtotecan Liposome in Treating Patients With Advanced Solid TumorsCompletedNCT00003891Phase 1
• MG98 in Treating Patients With Advanced Solid TumorsCompletedNCT00003890Phase 1
• Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
• Pilocarpine in Treating Patients With Dry Mouth Caused by OpioidsTerminatedNCT00003686Phase 3
• Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung CancerCompletedNCT00003685Phase 3

← NCIC Clinical Trials Group overview and focus areas